Endocarditis 2007: Results of a multicentric study on occurence and characteristics of infective endocarditis
Authors:
J. Beneš; R. Baloun; O. Džupová
Authors‘ workplace:
Klinika infekčních nemocí 3. lékařské fakulty UK a FN Na Bulovce Praha, přednosta doc. MUDr. Jiří Beneš, CSc. a skupina hlásících lékařů
Romana Balková (Nemocnice s poliklinikou Česká Lípa, a. s. ), Marián Branný (Nemocnice Třinec – Podlesí, s. r. o. )
Published in:
Vnitř Lék 2011; 57(2): 147-154
Category:
Original Contributions
Overview
Aim:
To recognize incidence and epidemiological characteristics of infective endocarditis (IE) in the Czech Republic.
Methods:
A prospective multicentre observational study on occurence and characteristics of IE in 29 hospitals within one year. A cooperative physician in every hospital reported all cases of IE that occured in pre-defined hospital attraction area in 12 consecutive months. A unified anonymous form was used for reporting. Only patients fulfilling the modified Duke criteria were enrolled.
Results:
One hundred and thirty-four cases of IE were reported. Thus, crude incidence of IE appeared 3.4 cases/100,000/year. Vegetations were found on aortic valves in 45.5% and on mitral valves in 40.3%. The most common etiological agent was Staphylococcus aureus (29.9%). Etiology was not established in 45 cases (33.6%), mostly due to previous antibiotic treatment. The most frequent predisposing conditions were purulent infections, namely in lower extremities, and previous invasive cardiac procedures (cardiac surgery, permanent pacemaker/defibrillator etc.). Heart surgery within antibiotic treatment was performed in 36 patients (26.9%). Overall mortality was also 26.9%. Mortality was significantly higher in hospitals that did not dispose of transesophageal echocardiography (TEE).
Conclusion:
We assume the real incidence of IE was slightly higher than we had found. The possible causes of such discreapance are discussed.
Key words:
infective endocarditis – incidence – predisposing conditions – echocardiography
Sources
1. Bayer AS, Scheld WM. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 5th ed. New York: Churchill Livingstone 2000: 857–902.
2. Eggimann P, Francioli P. L’endocardite infectieuse. Premiere partie: Epidemiologie, facteurs predisposants, pathogenese, agents etiologiques. Med Mal Infect 1993; 23: 774–780.
3. Miró JM, Wilson WR. Endocarditis infectiosa: Perspectivas hacia el 2000. Med Clin (Barc) 1995; 104: 55–58.
4. Griffin MR, Wilson WR, Edwards WD et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA 1985; 254: 1199–1202.
5. Walpot J, Blok W, van Zwienen J et al. Incidence and complication rate of infective endocarditis in the Dutch region of Walcheren: a 3-year retrospective study. Acta Cardiol 2006; 61: 175–181.
6. Tleyjeh IM, Steckelberg JM, Murad IS et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005; 293: 3022–3028.
7. Hogevik H, Olaison L, Andersson R et al. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine 1995; 74: 324–339.
8. Lee CH, Tsai WC, Liu PY et al. Epidemiological features of infective endocarditis in Taiwanese adults involving native valves. Am J Cardiol 2007; 100: 1282–1285.
9. de Sa DD, Tleyjeh IM, Anavekar NS et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2010; 85: 422–426.
10. Berlin JA, Abrutyn E, Strom BL et al. Incidence of infective endocarditis in the Delaware Valley, 1988–1990. Am J Cardiol 1995; 76: 933–936.
11. Beneš J, Kabelková M, Džupová O et al. Infekční endokarditida – pacienti hospitalizovaní na Infekční klinice Fakultní nemocnice Bulovka v letech 1990–1999. Cor Vasa 2000; 42: 389–396.
12. Pazdernik M, Baddour LM, Pelouch R. Infective endocarditis in the Czech Republic: eight years of experience at one of the country’s largest medical centers. J Heart Valve Dis 2009; 18: 395–400.
13. Šteiner I, Pácalt J. Infekční endokarditida – studie 153 případů. Česk Patol 1994; 30: 43–46.
14. Steiner I. Nonbacterial thrombotic versus infective endocarditis: A necropsy study of 320 cases. Cardiovasc Pathol 1995; 4: 207–209.
15. Hricak V, Kovacik J, Marx P et al. Etiology and risk factors of 180 cases of native valve endocarditis. Report from a 5-year national prospective survey in Slovak Republic. Diagn Microbiol Infect Dis 1998; 31: 431–435.
16. Hricak V, Liska B, Kovackova J et al. Trends in risk factors and etiology of 606 cases of infective endocarditis over 23 years (1984–2006) in Slovakia. J Chemother 2007; 19: 198–202.
17. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis if infective endocarditis. Clin Infect Dis 2000; 30: 633–638.
18. Vitouš A, Hobstová J. Infekční onemocnění problémových uživatelů drog hospitalizovaných na infekčním oddělení FN Motol v období 2002–2005. Klin Mikrobiol Inf Lék 2007; 13: 70–75.
19. Fournier PE, Thuny F, Richet H et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010; 51: 131–140.
20. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309–332.
21. Beneš J, Gregor P, Mokráček A. Infekční endokarditida. Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor Vasa 2007; 49: K157–K171. Available from: http://www.kardio-cz.cz/index.php?&desktop=clanky&action=view&id=684.
22. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2007; 138: 739–745, 747–760.
23. Kamalakannan D, Pai RM, Johnson LB et al. Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg 2007; 83: 2081–2086.
24. Ruiz M, Sánchez MP, Domínguez JC et al. Infective endocarditis in patients receiving chronic hemodialysis: clinical features and outcome. J Heart Valve Dis 2005; 14: 11–14.
25. Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Arch Intern Med 2004; 164: 71–75.
26. Francioli P. Central nervous system complications of infective endocarditis. In: Scheld WM, Whitley RJ, Durack DT (eds). Infections of the Central Nervous System. New York: Raven Press 1991: 515–568.
27. Schildberger J, Voháňka S, Brychta T et al. Neurologické komplikace u infekční endokarditidy. Prakt Lék 2002; 82: 731–734.
28. Murdoch DR, Corey GR, Hoen B et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463–473.
29. Čanádyová J, Mokráček A, Rezler M et al. Záchovné operácie aortálnej chlopne. Naše skúsenosti a strednedobé výsledky. Cor Vasa 2010; 52: 307–309.
30. Laca B, Páleníčková J, Kučerová S et al. Výsledky chirurgické léčby infekční endokarditidy. Cor Vasa 2010; 52: 332–339.
30. Pol J, Černý J, Ondrášek J et al. Diagnostika a výsledky chirurgické léčby infekční endokarditidy. Cor Vasa 2010; 52: 340–346.
31. Němec P, Frélich M, Štětka F et al. Izolované výkony na trikuspidální chlopni. Cor Vasa 2010; 52: 347–352.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2011 Issue 2
Most read in this issue
- Bicuspid aortic valve – ethiopathogenesis and natural history
- Alcoholic cardiomyopathy – still a topical diagnosis
- Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases – principles and rationale of CZEMP recommendations
- Evaluating of quality of life and functional status in patients with rheumatoid arthritis